An in vitro study demonstrated that OCT1 silencing impaired the cytotoxic effect of CDDP in ESCC cells, and that the level of OCT1 mRNA expression was downregulated in CDDP-resistant cells compared with the parental cells [11]. This evidence concerns the gene SLC22A1 and esophageal squamous cell carcinoma.